• Explore /
  • Poster
  • / Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Efficacy results of a phase II trial (AGMT MBC-6).

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Efficacy results of a phase II trial (AGMT MBC-6).

Abstract Poster

Authors

null

Gabriel Rinnerthaler

Paracelsus Medical University Salzburg, Salzburg, Austria

Gabriel Rinnerthaler , Simon Peter Gampenrieder , Daniela Voskova , Andreas L. Petzer , Michael Hubalek , Edgar Petru , Bernd Hartmann , Johannes Andel , Marija Balic , Hanno Ulmer , Thomas Melchardt , Brigitte Mlineritsch , Richard Greil

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT01891227

Citation

J Clin Oncol 34, 2016 (suppl; abstr 1032)

DOI

10.1200/JCO.2016.34.15_suppl.1032

Abstract #

1032

Poster Bd #

137

Abstract Disclosures

Similar Posters

First Author: In Hae Park

First Author: Min Yan

First Author: Zefei Jiang

First Author: Ayca Gucalp